RIM systems

How a regulatory information management platform handles global registrations — centralised data, standardised submissions, and tracking requirements across markets.

Essenvia CEO Soumya Mahapatra answers three common objections to RIM platforms: the cost, the disruption to existing workflows, and how long benefits take to appear.

The ever-evolving world of medical device regulations presents an era of continuous change, most notably with the EU’s Medical Device Regulation (MDR). Industry experts warn that noncompliance with the rule’s requirements could land MedTech manufacturers in hot water.

Different policies and submission procedures across countries and regions create a significant barrier to meeting regulatory deadlines and can easily become an intricate puzzle if there is not a centralized Regulatory (RIM) Platform to merge and automate all regulatory processes and data.

Class III PMA (pre-market approval) has a lot to offer for companies. In addition to getting clear approval for a device, Class III PMA also offers product protections similar in many respects to a patent, making it highly desirable.

Implementing a RIM platform can significantly enhance regulatory processes. However, several misconceptions often prevent medical device companies from adopting these platforms. In this webinar, we debunk the most common myths and demonstrate how RIM platforms can quickly generate ROI.

Why regulatory operations decide time-to-market — where manual submission assembly introduces errors, and what the FDA's refuse-to-accept rate reveals about them.